Pencil 50/Pencil 100

Pencil 50/Pencil 100 Adverse Reactions

cilostazol

Manufacturer:

Cadila Pharma

Distributor:

Kaufmann

Marketer:

Ambica
Full Prescribing Info
Adverse Reactions
The only adverse event resulting in discontinuation of therapy in >3% of patients treated with Cilostazol 50 or 100 mg b.i.d. was headache, which occurred with an incidence of 1.3%, 3.5%, and 0.3% in patients treated with CILOSTAZOL 50 mg b.i.d., 100 mg b.i.d. or placebo respectively.
Other frequent causes of discontinuation included palpitation and diarrhea, both 1.1% for cilostazol (all doses) versus 0.1% for placebo.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in